AI platform to generate, adapt, and consolidate value evidence—craft value messages, train teams, and measure impact.
Joined October 2025
- Tweets 38
- Following 4
- Followers 4
- Likes 137
35 Photos and videos
Your model projects patients you'll never treat
Late diagnosis. No specialist. Payer denial. Drop-off
If you're not tracking those leaks, you're overestimating everything
At Quantus, we map the real journey and build a concrete access plan
👉Comment LEAKS
3
11
Jun 11
The payer has 3 questions in every meeting. They never say them out loud.
If you don't answer them, the committee says no. Not because of your product — because of your message.
👉 Swipe to see them all.
Message us PAYER and let's talk.
#MarketAccess #Pharma #PayerEngagement
3
19
Jun 10
Local strategy or just a translated deck?
The payer evaluates their budget, their patients, and their risks — not the international average.
Translating ≠ localizing.
DM me LOCAL 👇
#MarketAccess #Quantus #LocalStrategy #HTA
3
14
The WHO 3x GDP per capita threshold is dead.
The WHO said so. Lancet Global Health confirmed it: 97% of countries sit below 1x GDP per QALY.
Brazil, Colombia and Peru already set their own. Is your dossier keeping up?
Country map for LATAM 👇 getquantus.ai/value-insights…
3
63
Does your team know how to use AI but not understand the process? That's called de-skilling.
Overreliance erodes critical thinking — and in healthcare, that's a real risk.
Comment BALANCE 👇 and I'll show you how to avoid it.
#AI #Healthcare #Pharma #Leadership
3
17
In LATAM pharma, pricing is never just pricing.
One decision can affect access, margins, and negotiations across multiple countries.
The smartest teams model regional impact before launch.
👇 Full blog here: getquantus.ai/value-insights…
#Pharma #Pricing #MarketAccess #LATAM
3
17
Evidence alone doesn’t win access.
HTA frameworks define how decisions are really made.
Teams that understand that logic build stronger dossiers and reduce friction with payers.
👇 Full blog here: getquantus.ai/value-insights…
#Pharma #HTA #MarketAccess #HEOR
3
15
May 28
AI is changing pharma faster than most teams realize.
Some companies are still testing.
Others are already transforming market access workflows.
The gap is growing.
👇 Full blog here: getquantus.ai/value-insights…
#Pharma #AI #MarketAccess #HTA
4
54
May 27
6 months of work.
4 minutes to read.
A “no.”
The problem isn’t your dossier.
It’s not answering:
👉 cost or savings?
💬 DM VALUE to see how to close with evidence.
#Pharma #MarketAccess #Healthcare
3
26
May 21
AI is already transforming pharma.
Now the regulations are coming.
🇪🇺 EU AI Act
🇺🇸 FDA draft guidance
⚠️ And still a lot of uncertainty.
👇 Comment COMPLY
#Pharma #AI #Regulation #MarketAccess
1
4
80
May 20
AI isn’t the advantage anymore.
Execution is.
Some teams are moving faster.
Others are still catching up.
The gap is real.
👇 Full blog here getquantus.ai/value-insights…
#Pharma #AI #MarketAccess #HTA
3
15
May 13
You have data.
You have evidence.
And still no decision.
It’s not the product.
It’s the story.
👉 Swipe
📩 DM VALUE STORY
#Pharma #MarketAccess #HEOR #HTA
3
22
You won the tender with AI…
But the market?
⬇️ -30% prices
⬇️ Margins
⬆️ Risk
Winning isn’t always winning.
👇 Comment VALUE
#Pharma #MarketAccess #AI #Pricing
3
10
Apr 30
You present evidence.
They say: “we’ll review it.”
And nothing happens.
It’s not interest.
It’s relevance.
👉 Swipe
📩 DM VALUE
#Pharma #MarketAccess #HEOR #HTA
3
12
Apr 29
3 HTA agencies in LATAM.
0 clear AI rules.
But dossiers with AI are already arriving.
The advantage will go to teams that use AI with
traceability, validation, and rigor.
👇 Read the full blog here: getquantus.ai/value-insights…
#Pharma #MarketAccess #HEOR #AIinHealthcare #HTA
3
29
Apr 28
CONITEC and IETS still have no clear AI guidance for HTA evidence.
That’s not a pause.
It’s a window to set the benchmark.
The teams that document rigor today will lead tomorrow.
👇Read the full blog here: getquantus.ai/value-insights…
#Pharma #MarketAccess #HEOR #AIinHealthcare
3
20
Apr 22
Your product isn’t expensive.
You’re telling the wrong story.
Payers care about disease cost, not price.
👉 Swipe
📩 DM REAL COST
#Pharma #MarketAccess #HEOR #HTA
3
19
Apr 17
$15K in training…
80% forgotten in weeks
❌ Not your team
❌ Your training model
🚀 No practice = no performance
📩 DM: MASTERY
3
11
Apr 16
Most pharma teams still spend 4–8 months building a GVD.
AI is cutting that to weeks.
Same rigor.
Faster payer readiness.
👇 Read the full blog here---> getquantus.ai/value-insights…
#Pharma #MarketAccess #HEOR #AIinHealthcare #HTA
3
25
Apr 15
A Global Value Dossier no longer needs 4–8 months.
AI is already turning months into weeks—with the same methodological rigor.
The real edge?
Getting to HTA windows first.
👇 Read the full blog here--> getquantus.ai/value-insights…
#Pharma #MarketAccess #HEOR #AI #HTA #GVD
3
18